What Does Eligo Bioscience Do?

Total employees45
HeadquartersRomainville (Greater Paris)
Founded2014

Eligo Bioscience is a clinical-stage biotechnology company pioneering the development of novel, CRISPR-based drugs called Eligobiotics® to selectively target and modify the microbiome. Their innovative approach aims to address a wide range of diseases by precisely editing the genetic makeup of bacteria within the gut and other microbial ecosystems, offering potential treatments for conditions from infectious diseases to inflammatory disorders and beyond. Eligo's technology allows for the selective eradication of pathogenic bacteria or the delivery of therapeutic genes to beneficial bacteria, marking a significant advancement in precision medicine.

Where Is Eligo Bioscience's Headquarters?

HQ Function

Primary research and development (R&D) labs, corporate operations, strategic partnerships, and administrative functions.

Notable Features:

State-of-the-art laboratory facilities equipped for advanced microbiology, molecular biology, and gene editing research, including BSL-2 capabilities. Part of the Biocitech campus, fostering collaboration and innovation.

Work Culture:

A dynamic, science-driven, and innovative environment focused on cutting-edge research. Emphasizes collaboration, intellectual curiosity, and a mission to translate scientific breakthroughs into impactful therapies.

HQ Significance:

The headquarters serves as the central nervous system for Eligo's pioneering work in microbiome gene therapy, strategically positioned within a leading European biotech ecosystem to leverage talent and partnerships.

Values Reflected in HQ: The HQ's focus on advanced R&D facilities reflects Eligo's commitment to scientific excellence, innovation, and rigorous research in developing its groundbreaking therapies.

Location:

Eligo Bioscience's core operations and R&D are centered in Paris, France. They maintain a global outlook through international collaborations, participation in global scientific conferences, and a strategic presence in key biotech hubs like Cambridge, MA, USA, to support business development, clinical trial activities, and investor relations worldwide as their therapeutic pipeline advances.

Street Address:

102 Av. Gaston Roussel

City:

Romainville (Greater Paris)

State/Province:

Île-de-France

Country:

France

Where Else Does Eligo Bioscience Operate Around the World?

Cambridge, MA, USA

Address: Not publicly specified; likely a strategic presence or collaborative office rather than a full R&D site.

To engage with the North American biotech ecosystem, facilitate partnerships, and access US capital markets and clinical research expertise.

Buying Intent Signals for Eligo Bioscience

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Eligo Bioscience? Meet the Executive Team

As of April 2025, Eligo Bioscience' leadership includes:

Dr. Xavier Duportet - Co-founder & Chief Executive Officer
Dr. David Bikard - Co-founder & Chief Scientific Officer
Dr. Sophie LIPSETT - Chief Medical Officer
Aurélie Grienenberger - Chief Business Officer
Kevin GOULEY - Chief Financial Officer
Dr. Asma Al-Oul - Head of Clinical Development

Who's Investing in Eligo Bioscience?

Eligo Bioscience has been backed by several prominent investors over the years, including:

Khosla Ventures
Seventure Partners (including Health for Life Capital)
Bpifrance (Large Venture fund)
Sanofi Ventures
Merck KGaA (M Ventures)
Omnes Capital
Medicxi

What Leadership Changes Has Eligo Bioscience Seen Recently?

Hire1
Exits0

Eligo Bioscience has strengthened its leadership, notably with the appointment of a new Chief Medical Officer in late 2023. The company continues to build its team to support clinical development.

New Appointments:

Dr. Sophie LIPSETT, Dr. Sophie Lipsett joined Eligo Bioscience as Chief Medical Officer, bringing extensive experience in clinical development and translational medicine to advance Eligo's pipeline programs.

What Technology (Tech Stack) Is Used byEligo Bioscience?

Discover the tools Eligo Bioscience uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Eligo Bioscience Email Formats and Examples

Eligo Bioscience commonly uses the email format combining the first initial and last name, or first name and last name separated by a dot, followed by @eligo.bio. This is a standard convention for many biotechnology companies.

[first_initial][last]@eligo.bio or [first].[last]@eligo.bio

Format

jdoe@eligo.bio or jane.doe@eligo.bio

Example

85%

Success rate

What's the Latest News About Eligo Bioscience?

Eligo Bioscience Press ReleaseNovember 29, 2023

Eligo Bioscience Appoints Dr. Sophie Lipsett as Chief Medical Officer

Eligo Bioscience announced the appointment of Dr. Sophie Lipsett as Chief Medical Officer. Dr. Lipsett will oversee the clinical development strategy and operations for Eligo's pipeline of innovative microbiome gene therapies....more

Eligo Bioscience Press ReleaseSeptember 7, 2023

Eligo Bioscience Receives FDA Fast Track Designation for EB005 for the Treatment of Recurrent Clostridioides difficile Infection

Eligo Bioscience announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to EB005, its investigational therapy for the treatment of recurrent Clostridioides difficile Infection (rCDI). EB005 is designed to selectively eliminate C. difficile bacteria from the gut microbiome....more

Eligo Bioscience Press ReleaseJune 12, 2023

Eligo Bioscience Presents Preclinical Data on EB005 at ASM Microbe 2023, Demonstrating Potent and Selective C. difficile Killing

Eligo Bioscience presented promising preclinical data for EB005 at the American Society for Microbiology (ASM) Microbe 2023 conference. The data showcased EB005's ability to potently and selectively kill Clostridioides difficile bacteria while preserving beneficial commensal bacteria in complex human gut microbiome models....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Eligo Bioscience, are just a search away.